For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...

Zoliflodacin demonstrated high microbiological cure rates for uncomplicated urogenital gonorrhea, with 90.9% efficacy in the general population. The trial was open-label and had limited representation ...

No one wants to hear that they’ve contracted a sexually transmitted infection (STI). Having one can mean discomfort, inconvenience, potential embarrassment and often requires putting intimacy on hold ...

A one-dose oral drug called zoliflodacin has proven highly effective against gonorrhoea in a major international trial. The pill matched the success of current treatments while avoiding injections and ...